PRS9 COST OF COMMUNITY ACQUIRED PNEUMONIA (CAP) TREATMENT WITH KETEK (TELITHROMYCIN) VS CLARITHROMYCIN FROM PUBLIC PAYER PERSPECTIVE IN POLAND
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67805-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)67805-9/fulltext
Title :
PRS9 COST OF COMMUNITY ACQUIRED PNEUMONIA (CAP) TREATMENT WITH KETEK (TELITHROMYCIN) VS CLARITHROMYCIN FROM PUBLIC PAYER PERSPECTIVE IN POLAND
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67805-9&doi=10.1016/S1098-3015(10)67805-9
First page :
Section Title :
Open access? :
No
Section Order :
406